首页 > 市场调查报告书 > 製药

动物用医药

兽用人工授精市场规模、份额和成长分析（按动物类型、产品、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1900758

兽用人工授精市场规模、份额和成长分析（按动物类型、产品、最终用户和地区划分）－2026-2033年产业预测

Veterinary Artificial Insemination Market Size, Share, and Growth Analysis, By Animal Type (Cattle, Ovine Caprine), By Product (Equipment & Consumables, Semen), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 154 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，兽用人工授精市场规模将达到 83.4 亿美元，到 2025 年将达到 88.7 亿美元，到 2033 年将达到 145 亿美元，预测期（2026-2033 年）的复合年增长率为 6.34%。

受多种关键因素的驱动，兽用人工授精市场正在成长，这些因素包括对永续食品生产的需求、性别选择精液的应用以及提高动物生产力的需要。这一趋势反映了肉类、牛奶和乳製品消费量的成长。兽用人工授精服务的日益普及至关重要，因为专业机构专注于各种动物的人工授精程序，并透过专业的精液采集和处理来提高受孕率。繁殖管理计划是这些服务的补充，为育种者提供全面的策略来指导其完成整个繁殖週期。这些服务通常包括发情同步、生育力测试、超音波和生殖健康评估，所有这些都有助于提高受孕率、优化繁殖效率，并最大限度地减少育种者和宠物饲主可能遇到的繁殖併发症。

全球兽用人工授精市场依产品种类、动物种类、技术、应用及地区细分。按产品类型划分，市场分为设备和耗材以及精液。依动物种类划分，市场分为牛、猪、牛、山羊、马和其他动物。依技术划分，市场分为子宫内授精、输卵管授精、腹腔内授精、子宫颈内授精、子宫内授精及输卵管内授精。按最终用户划分，市场分为兽医诊所、畜牧场和其他。依地区划分，市场分为北美、欧洲、亚太、拉丁美洲以及中东和非洲。

兽用人工授精市场驱动因素

兽用人工授精市场的主要驱动力在于其能够促进安全可控的育种计划，从而有效遏制动物群体中疾病的传播。这项技术透过使用来自无病或抗病牛的精液，最大限度地降低了感染疾病传播给后代的风险。此外，它还可以透过消除动物在配种过程中的直接接触，有助于疾病预防。而且，使用经过健康检测的牛的精液对母牛进行人工授精的做法，符合疾病根除工作的要求，并有助于逐步消除群体中的疾病。这项技术使育种者能够利用抗病牛品系的可靠精液，选择性地培育出具有更强抗病能力的品种。

兽医人工授精市场的限制

兽医人工授精市场面临的一大障碍是先进技术和设备的高昂成本。精准育种技术，例如使用性别选择精液和先进的生殖技术，都需要大量投资。兽医诊所和农场在购买设备、维护以及有效实施这些技术所需的培训方面都面临着高昂的成本。因此，许多营业单位，特别是小规模企业和发展中地区的机构，可能对采用和使用先进的人工授精方法犹豫不决。这种经济挑战可能会阻碍市场扩张，并导致各行业的采用率较低。

兽用人工授精市场趋势

兽用人工授精市场正呈现显着的趋势，即整合先进的基因技术。基因组学和基因选择工具等创新技术正被越来越多地用于优化性状选择，从而提高育种效果。特别是，使用性别选择精液能够生产出所需性别的后代，而基因组学技术的进步也有助于提高牲畜的遗传品质。这些技术进步显着提高了育种计划的效率和牲畜的整体生产力。随着这些先进基因解决方案的不断普及，我们预期兽用人工授精市场将进一步成长和发展。

北美洲
- 美国
- 加拿大
欧洲
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

URUS Group LP
Genus
CRV
Semex
IMV Technologies
Select Sires Inc
Swine Genetics International
Shipley Swine Genetics
Stallion AI Services Ltd
STgenetics
Strategy Mapping
Kruuse Ltd.
AgTech Inc.
Boehringer Ingelheim
Elanco Animal Health
Bovine Elite LLC
ABS Global Inc.
Santa Cruz Biotechnology
Neogen Corporation
Iherdsman

结论与建议

简介目录

Product Code: SQMIG35A2962

Veterinary Artificial Insemination Market size was valued at USD 8.34 Billion in 2024 and is poised to grow from USD 8.87 Billion in 2025 to USD 14.5 Billion by 2033, growing at a CAGR of 6.34% during the forecast period (2026-2033).

The Veterinary Artificial Insemination market is experiencing growth driven by several key factors, including the demand for sustainable food production, the application of sexed semen, and the need for enhanced animal productivity. This trend reflects the rising consumption of meat, milk, and dairy products. Increased adoption of Veterinary artificial insemination services is crucial as professional providers specialize in AI procedures across various animal species, enhancing conception rates through expert semen collection and processing. Reproductive management plans complement these services, offering comprehensive strategies to guide breeders through the breeding cycle. Services typically include estrus synchronization, fertility testing, ultrasound exams, and reproductive health assessments, all of which significantly help breeders and pet owners improve conception rates, optimize reproductive efficiency, and minimize reproductive complications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Veterinary Artificial Insemination market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Veterinary Artificial Insemination Market Segments Analysis

Global Veterinary Artificial Insemination Market is segmented into product, animal type, technique, end use, and region. By Product, the market is segmented into Equipment & Consumables, and Semen. By animal type, the market is segmented into Cattle, Swine, Bovine, Ovine Caprine, Equine, and Other Animals. By technique, the market is segmented into Intrauterine tub peritoneal insemination, Intracervical insemination, Intrauterine insemination, Intratubal insemination. By end user, the market is segmented into veterinary hospitals, animal husbandry, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Veterinary Artificial Insemination Market

The Veterinary Artificial Insemination market is significantly driven by its ability to facilitate safe and controlled breeding programs, which effectively mitigate the spread of diseases among animal populations. This technique minimizes the risk of transmitting infections to offspring by allowing breeders to utilize semen from sires confirmed to be disease-free or resistant. The method also helps prevent epidemics by eliminating direct contact between animals during breeding. Furthermore, the practice of inseminating females with semen from health-tested sires aligns with disease eradication initiatives, supporting the gradual elimination of illnesses from the population. This technology empowers breeders to selectively breed for enhanced disease resistance using trusted semen from resilient sire lines.

Restraints in the Veterinary Artificial Insemination Market

A significant barrier to the veterinary artificial insemination market is the considerable cost associated with advanced technology and equipment. Precision breeding techniques, such as the use of sexed semen and sophisticated reproductive technologies, demand substantial investment. Veterinary practices and farms face high expenses related to purchasing machinery, its upkeep, and necessary training to implement these technologies effectively. As a result, many businesses, particularly smaller firms and those in developing regions, may be deterred from embracing and utilizing advanced artificial insemination methods. This financial challenge can hinder market expansion and lead to minimal adoption rates across various segments.

Market Trends of the Veterinary Artificial Insemination Market

The veterinary artificial insemination market is witnessing a notable trend towards the integration of advanced genetic technologies. Innovations such as genomics and genetic selection tools are increasingly being utilized to refine trait selection, leading to improved breeding outcomes. Notably, the use of sexed semen allows for the production of preferred offspring genders, while genomic advancements contribute to enhanced genetic quality in livestock. These technological enhancements have significantly increased the efficiency of breeding programs and overall livestock productivity. As the adoption of these advanced genetic solutions continues to expand, further growth and evolution in the veterinary artificial insemination market are anticipated.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis

Global Veterinary Artificial Insemination Market Size by Product & CAGR (2026-2033)

Market Overview
Equipment & Consumables
Semen
- Normal
- Sexed

Global Veterinary Artificial Insemination Market Size by Animal Type & CAGR (2026-2033)

Market Overview
Bovine
Swine
Ovine & Caprine
Equine
Other Animals

Global Veterinary Artificial Insemination Market Size by Technique & CAGR (2026-2033)

Market Overview
Intrauterine tub peritoneal insemination
Intracervical insemination
Intrauterine insemination
Intratubal insemination

Global Veterinary Artificial Insemination Market Size by End user & CAGR (2026-2033)

Market Overview
Veterinary Hospitals
Animal Husbandry
Others

Global Veterinary Artificial Insemination Market Size & CAGR (2026-2033)

North America, (Product, Animal Type, Technique, End User)
- US
- Canada
Europe, (Product, Animal Type, Technique, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product, Animal Type, Technique, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product, Animal Type, Technique, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product, Animal Type, Technique, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

URUS Group LP
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genus
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CRV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Semex
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IMV Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Select Sires Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Swine Genetics International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shipley Swine Genetics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stallion AI Services Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STgenetics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Strategy Mapping
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kruuse Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AgTech Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elanco Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bovine Elite LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ABS Global Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Santa Cruz Biotechnology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neogen Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Iherdsman
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments